FDA, Roche to implement new dispensing procedures for isotretinoin.
Young
D
D
D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D004345:Drug Industry; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects* / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D013723:Teratogens; D014481:United States; D014486:United States Food and Drug Administration
D007641:Keratolytic Agents; D013723:Teratogens; D015474:Isotretinoin